Analysts think MEDP stock price could increase by 5%
Mar 10, 2026, 11:25 AM
0.43%
What does MEDP do
Medpace Holdings, headquartered in Cincinnati, Ohio, offers outsourced clinical development services to the biotechnology and pharmaceutical industries, employing 5,800 staff since its IPO in 2016. The firm specializes in full-service Phase I-IV clinical trial support across North America, Europe, and Asia.
14 analysts think MEDP stock price will increase by 5.04%. The current median analyst target is $502.35 compared to a current stock price of $478.25. The lowest analysts target is $341.82 and the highest analyst target is $611.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.